Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repairHai Liu, Xiaonan Sun(Sir Run Run Shaw Hospital)OncoTargets and TherapyFebruary 1, 201510.2147/ott.s76958Cited by 17SaveCiteExport RISWatch citationsRelated Papers<div>Icotinib hydrochloride enhances chemo- and radiosensitivity by inhibiting EGFR signaling and attenuating RAD51 expression and function in Hela S3 cells</div>|OncoTargets and Therapy|2018|10